Torbay Pharma
Mark Andrews is currently the Quality and Technical Director at Torbay Pharmaceuticals. Prior to this, Mark held various leadership roles at South Devon Healthcare NHS Foundation Trust and South Devon Healthcare Trust. Mark has a Master of Business Administration degree from the University of Exeter Business School and a MSc in Pharmaceutical Sciences from the University of Leeds.
Torbay Pharma
Torbay Pharma is a licence holder and global specialist in the manufacture and supply of terminally sterilized injectables for the secondary care market. We work with generic pharmaceutical companies seeking to ensure their sterile injectable products get to market reliably and without delay. As a CMO and CDMO, we offer fill/finish services for terminally sterilised injectables into plastic and glass vials and ampoules. Our specialist portfolio includes licensed and unlicensed terminally sterilised injectables, electrolyte solutions for total parenteral nutrition (TPN) compounding and a range of non-sterile oral solutions. Established in the 1970s as part of the Torbay and Devon NHS Foundation Trust, we have grown into a 250-strong team operating from our purpose built manufacturing facility in Paignton, UK. November 2023 saw us receive investment from NorthEdge, we’re now Torbay Pharmaceuticals Ltd. Torbay Pharma offer niche product experience and capabilities, an agile approach and a team of experts who genuinely care. Our determination and flexibility at every step, ensure quality products are efficiently supplied to market, with clear communication and consultancy throughout the process. If you think we can help you with your next project, visit our website: www.torbaypharma.com